Ventana and TriPath form global alliance:
This article was originally published in Clinica
Executive Summary
Ventana Medical Systems and TriPath Imaging have entered a five-year supply partnership for TriPath's interactive histology imaging system. Under the terms of the agreement, Ventana obtained exclusive worldwide rights to sell and distribute the product under its own brand and to optimise it for assays developed by both Tucson, Arizona-based Ventana and Burlington, North Carolina-based TriPath. The system offers on-demand digital imaging, direct visualisation of immunohistochemistry stained slides and real time quantitative analysis of tissue samples.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.